ÍÎÂÛÉ ÍÀÓ×ÍÛÉ ÒÐÓÄ ÏÎ ÃÎÌÅÎÏÀÒÈÈ È ÊÎÐÎÍÀÂÈÐÓÑÓ ÎÏÓÁËÈÊÎÂÀÍ Â ÁÐÀÇÈËÈÈ
Èçâåñòíûé ñâîèìè ìíîãî÷èñëåííûìè òðóäàìè áðàçèëüñêèé èññëåäîâàòåëü Ìàðêóñ Äæóëèàí Òåéøåéðà îïóáëèêîâàë â âèðòóàëüíîé áèáëèîòåêå çäîðîâüÿ (VHL), íà 62 ñòðàíèöàõ, áîëüøîé òðóä ïî ãîìåîïàòèè è êîðîíàâèðóñó. Ê ñîæàëåíèþ, ëèøü ÷àñòü òðóäà íà àíãëèéñêîì ÿçûêå (Clinical Research Protocol to Evaluate the Efficacy and Safety of Individualized Homeopathic Medicine in the Treatment and Prevention of the Covid-19 Epidemic - Teixeira, Marcus Julian), íî äëÿ òåõ, êòî íå çàáûë ëàòûíü, îñíîâíûå ïîëîæåíèÿ ïîðòóãàëîÿçû÷íîé ïóáëèêàöèè ïðî÷èòàòü âîçìîæíî. Ññûëêà íà áèáëèîòå÷íûé ôîíä:
https://pesquisa.bvsalud.org/portal/resource/en/biblio-1087238